Canon produces 'Stand By You,' an emotional ultra-high-resolution short film set in Taiwan that effectively utilizes aesthetic blurring of out-of-focus areas

The future of photography and videography is in Canon's hands, with five 2019 EISA Awards

Canon, Canon Medical and CiRA to commence joint research aimed at realizing high-quality autologous iPS cells

TOKYO, August 1, 2019—Canon Inc. (Headquarters: Ohta-ku, Tokyo, Japan; Chairman & CEO: Fujio Mitarai) Canon Medical Systems Corporation ("Canon Medical"; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University ("CiRA"; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine through the realization of higher-quality induced pluripotent stem (iPS) cells¹ for autograft purposes, or "my iPS cells²."